# QUINCY DRUG DEVELOPMENT, LLC — Form D

QUINCY DRUG DEVELOPMENT, LLC of MADISON, WI, a company, filed a Form D exempt-offering notice with the SEC on 2011-12-09. The offering totals $170K, of which $7K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2011-12-09
- Form: D
- Accession: 0000892712-11-000989
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $170K
- Amount sold: $7K
- Remaining: $163K
- Investors: 17
- Date of first sale: 2011-12-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-169862

## Issuer

- Name: QUINCY DRUG DEVELOPMENT, LLC
- CIK: 0001536864
- Entity type: Limited Liability Company
- Jurisdiction: WISCONSIN
- Incorporated: 2011
- Address: 301 SOUTH WESTFIELD ROAD, MADISON, WI, 53717
- Phone: 608-827-8000

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Michael J Beaman | Executive Officer | Madison, WI |
| Mark Y Underwood | Executive Officer | Madison, WI |

## More

- [CIK 1536864 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1536864&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0000892712-11-000989.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.